Marriott’s Sorenson to Stay in Role During Cancer Treatment, Cites Confidence in Future

BETHESDA, MD—Marriott International Inc.’s president and CEO Arne Sorenson was diagnosed on Wednesday with stage 2 pancreatic cancer. Sorenson, 60, received the diagnosis from a medical team at Johns Hopkins Hospital in Baltimore after a series of tests. Sorenson will remain in his role while undergoing treatment.

In a message to Marriott International associates, Sorenson noted: “The cancer was discovered early. It does not appear to have spread and the medical team—and I—are confident that we can realistically aim for a complete cure. In the meantime, I intend to continue working at the company I love. Let me make one request, look ahead with me. We have great work underway at Marriott. I am as excited by what we can accomplish together as I have ever been.”

Sorenson’s treatment plan will begin next week with chemotherapy. His doctors anticipate surgery near year end 2019.

Leave A Reply